SCHEMBL28342443

SCHEMBL28342443

NC(=O)OCCc1ccc2c(c1)OCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 P11229 10/20 0.50
▸ CHRM3 P20309 5/20 0.50
▸ CHRM2 P08172 4/20 0.50
▸ CHRNB2 P17787 1/20 0.50
▸ CHRNA4 P43681 1/20 0.50
▸ CHRM5 P08912 9/20 0.43
▸ CHRM4 P08173 4/20 0.43
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ NPC1 O15118 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ YWHAG P61981 1/20 0.36
▸ APP P05067 1/20 0.36
▸ ADRB2 P07550 1/20 0.36
▸ ADRB1 P08588 1/20 0.36
▸ ADRA2A P08913 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ KCNE1 P15382 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28342373 0.93 CHRM1 (0.44) CHRM1CHRM3CHRM2CHRNB2CHRNA4
SCHEMBL28342389 0.89 CHRM5 (0.53) CHRM1CHRM3CHRM2CHRM5CHRM4
SCHEMBL28339934 0.82 CHRM5 (0.48) CHRM1CHRM3CHRM2CHRM5CHRM4
SCHEMBL11874562 0.79 CYP3A4 (0.57) CHRM1CHRM3CHRM5CYP3A4CYP2C19
SCHEMBL28342441 0.78 NPC1 (0.46) LMNANPC1RAB9A
SCHEMBL17726436 0.77 CHRM2 (0.55) CHRM1CHRM3CHRM2CHRNB2CHRNA4
SCHEMBL17726330 0.77 TAAR1 (0.56) CHRM1CHRM3CHRM2CHRNB2CHRNA4
SCHEMBL28342439 0.77 LMNA (0.41) CHRM1CHRM3CHRM2CHRM5CHRM4
Hydrochloric Acid SCHEMBL20563250 0.75 TAAR1 (0.54) CHRM1CHRM3CHRM2CHRNB2CHRNA4
SCHEMBL20563004 0.74 CHRM2 (0.50) CHRM1CHRM3CHRM2CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110612299-A Pyrimidine derivatives as PGE2 receptor modulators 爱杜西亚药品有限公司 2019-12-24 — — CN disclosed
Send feedback